Next Article in Journal
Antioxidant and Antiproliferative Activities of Eclipta prostrata (L.) L. Extract and Isolated Compounds
Previous Article in Journal
Recent Advances in the Synthesis and Antioxidant Activity of Low Molecular Mass Organoselenium Molecules
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Novel Schiff Base Derived from Amino Pyrene: Synthesis, Characterization, Crystal Structure Determination, and Anticancer Applications of the Ligand and Its Metal Complexes

Department of Chemistry, Faculty of Science, King Abdulaziz University, Jeddah P.O. Box 23622, Saudi Arabia
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(21), 7352; https://doi.org/10.3390/molecules28217352
Submission received: 3 October 2023 / Revised: 25 October 2023 / Accepted: 26 October 2023 / Published: 30 October 2023

Abstract

:
In this study, we report the cytotoxicity of a newly synthesized Schiff base HL ((E)-2-ethoxy-6((pyren-1-ylimino)methyl)phenol) and its derived metal complexes (Zn(II), Cu(II), Co(II), Cr(III), and Fe(III)) along with their structural characterizations by means of elemental analysis, magnetic moment, molar conductance, IR, UV-Vis, ESR, and mass spectrometry. The single X-ray diffraction of the HL shows that it exists in the phenol-imine form in its solid state. The NMR and IR data indicate that the bidentate binding of the Schiff base ligand with the metal center occurs during complexation through the azomethine nitrogen atom and the hydroxyl group oxygen atom of the 3-ethoxy salicylaldehyde. The electronic spectra and magnetic measurements indicate that the Co(II) complex has a tetrahedral geometry and that the Cr(III) and Fe(III) complexes have a distorted octahedral geometry. The ESR and electronic spectra suggest that the Cu(II) complex has a distorted tetrahedral geometry. The cytotoxic effects of the HL and all of the metal complexes were studied using human breast cancer (MCF-7) cells. The Cu(II) and Zn(II) complexes exhibited the highest activity against the tested cell line, with IC50 values of 5.66 and 12.74 μg/mL, respectively, and their activity was higher than that of the fluorouracil cancer drug against the MCF-7 cells (18.05 μg/mL).

1. Introduction

Breast cancer is a pressing issue for public health worldwide, being the second deadliest cancer for women. In recent years, there has been a drastic increase in breast cancer incidence. The need for the development of improved drugs for breast cancer treatment has become increasingly urgent due to the emergence of resistance in breast cancer cells following initially effective chemotherapy. To better understand breast cancer susceptibility and cellular responses to apoptosis, the estrogen receptor-positive MCF-7 cell line, derived from a patient with metastatic breast cancer, has served as a prominent model system [1].
Schiff bases, which are known for their coordination ability, hold significant importance as ligands in inorganic chemistry [2]. These compounds are synthesized through condensation reactions between amines and aldehydes or ketones under specific conditions. Schiff bases have garnered extensive research attention due to their facile formation, remarkable structural properties, strong binding capabilities, their use in diverse applications in the pharmaceutical industry, and their biological activities, such as their antibacterial [3], antifungal, and antitumor activities [4]. Notably, they play a crucial role in coordination chemistry by forming stable complexes with transition, non-transition, and inner transition metals, and their properties are significantly enhanced by doing so. Their ability to form stable complexes with metal ions is attributed to the presence of the azomethine (N=CH) lone pair of electrons in their structure. These complexes and their biological activities have been widely studied in the literature due to their selectivity towards a variety of organisms [5,6].
Heterocyclic Schiff bases are fundamentally important because of their elevated biological activities and their role in the development of novel materials with unique properties that can be modified by varying the substituents. One very interesting and promising class of heterocyclic Schiff base is the series of pyrene-based Schiff bases, which have been reported to be selective chemosensors for the detection of Fe(III) [7,8], Cu(II) [7,9], sulfide ions [9], and Al3+ and Ga3+ [10]. Srinivasan et al. developed two novel Schiff base compounds that are pyrene based, referred to as KSB-1 and KSB-2. They also investigated their antimicrobial activities against some pathogenic strains and reported that their AIE (aggregation-induced emission) properties make them prospective biomaterials for in vitro bioimaging and BSA-binding studies [8]. Recently, a monomeric Schiff base was synthesized via a reaction between o-vanillin and 1-aminopyrene. Interestingly, it exhibited a distinctive sensitivity to Sn2+ in comparison with various other metal ions [11]. However, the cytotoxic activities of pyrene-based Schiff base complexes are scarce or lacking.
Trace elements such as iron, copper, and zinc, along with ultra-trace elements like cobalt and chromium, are essential for supporting the proper function of various physiological and metabolic processes within living tissues. These complexes are crucial in maintaining the integrity of these processes [12].
In continuation of our work in the area of Schiff base complexes [13,14], this research paper reports the synthesis, characterization, and crystal structure of a Schiff base HL and its Zn(II), Cu(II), Co(II), Fe(III), and Cr(III) complexes. The Schiff base possesses N and O donor sites and exhibits excellent coordination potential for binding with various metal ions. Hence, it was of interest to prepare a pyrene-based Schiff base and its metal complexes to study their chemistry and evaluate their cytotoxic effects on a human breast cancer cell line (MCF-7 cells) by applying the MTT colorimetric assay.

2. Results and Discussion

2.1. Chemistry and Characterizations

The HL, ((E)-2-ethoxy-6((pyren-1-ylimino)methyl)phenol), derived from 3-ethoxy salicylaldehyde and 1-aminopyrene, was prepared according to Scheme 1, and a good yield was obtained under reflux conditions using ethanol as a solvent. The products were re-crystallized via the slow evaporation of the solvent at room temperature. All new metal complexes (M(L)(Cl)x(H2O)y where M = Zn or Cu, x = y = 1; M = Fe or Cr, x = y = 2; and M(L)2 where M = Co) were synthesized via direct reactions between the ligand and the corresponding metal chloride salts (Figure 1). The ligand and the complexes were stable at room temperature and insoluble in methanol and ethanol but soluble in DMF and DMSO. They were thoroughly characterized using FT-IR, elemental analysis, UV–Vis, 1H NMR, 13C NMR, and mass spectral studies. The structure of the Schiff base was established using X-ray crystallography. The results reveal that the Zn(II), Cu(II), and Co(II) complexes have a tetrahedral geometry, while the Fe(III) and Cr(III) complexes exhibit octahedral coordination around their central metal ions. The molar conductances of these compounds were measured in DMSO (1 × 10−3 M) at 25 °C, and the results indicate that they are non-electrolytic in nature (2.05–15.15 Ω−1 cm2 mol−1) [15]. Non-electrolytic complexes indicate that the anions are found in the coordination sphere. Also, the melting point values are greater than 210 °C. The data from the elemental analysis of the Schiff base and its complexes (Table 1) agree with the structure of the ligand shown in Scheme 1 and with the structures of the complexes shown in Figure 1.

2.1.1. XRD Analysis of HL

Structure elucidation was carried out on HL using the single-crystal X-ray diffraction technique. A study of the (E)-2-ethoxy-6-((pyren-1-ylimino)methyl)phenol compound was carried out, and the data obtained are presented in Table 2. Selected geometric parameters like bond length and bond angle are listed in Table 3.
The compound’s crystal structure was determined in a triclinic space group P1, with a formula unit of “C25H19NO2” and Z = 2. A perspective view of the compound is provided in Figure 2, which shows an intramolecular (O2-H2…N1) hydrogen bond (O…N = 2.580(3), O-H = 0.84, H…N = 1.84, and OH…N = 146.3°), involving the O-H group and the azomethine N atom, which is a characteristic hydrogen bond for Schiff bases that leads to the formation of an S(6) six-membered ring [16]. In Schiff bases, two distinct forms of intra-molecular hydrogen bonds can occur, which involve stabilization in either the keto-amine form (N-H…O hydrogen bond) [17] or the phenol-imine (N…H-O hydrogen bond) form [18]. In this X-ray study, it is revealed that HL, in its solid-state form, functions as a Schiff base and exists in the phenol-imine form. The bond length between C8 and N1 (1.282(3) Å) validates the presence of a double bond and is consistent with similar values found in other Schiff bases [19]. Additionally, the bond length C7-N1 (1.415(3) A°) is typical for a single bond. In the title compound, C25H19NO2, the pyrene ring system is inclined to the planar benzene ring system by 32.38°, and the conformation around the N=C bond is found to be E. Within the crystal structure, molecules are connected through C-H···π interactions (Figure 3).

2.1.2. NMR Spectral Studies (1H and 13C NMR Spectra)

The ligand 1H NMR spectrum obtained in DMSO-d6 displays the following signals outlined in Table 4 and depicted in Figure S1 (an expanded region between 6 and 9 ppm is shown in Figure S2). The pyrene multiplets are seen at δ 8.49–8.12 ppm, and the H1 proton at δ 8.12 is seen as a triplet with a coupling constant of 8.04 Hz. The signal at δ 9.28 corresponds to the azomethine proton (-CH=N-) and appears as a singlet. The broad peak observed at δ 13.61 ppm is associated with the phenolic OH group within the ligand. Furthermore, the signal at δ 1.43 ppm, displaying a triplet pattern with J = 7.07 Hz, is attributed to the methyl group of the ethoxy substituent attached to the benzene ring, while the signal at 4.14 ppm, appearing as a quartet with J = 7.07 Hz, is assigned to the -CH2 protons of the ethoxy group. The ligand’s 13C NMR spectrum is obtained in DMSO-d6, and the data from this spectrum validate the findings observed in the 1H NMR spectrum. The number of signals in the 13C NMR spectrum aligns with the number of magnetically distinct carbon atoms in the ligand (Figure S3). The carbon atom of the azomethine group is detected at a chemical shift of δ 164.97 ppm. The Ar-C-N carbon, phenolic carbon, and Ar-C-OEt carbon are visible at δ 151.25, 147.61, and 142.06 ppm, respectively. Peaks in the region δ 131.46–116.80 ppm are due to the remaining pyrene and aromatic carbons. The carbon atom in the methyl group of the ethoxy substituent is detected at a chemical shift of 15.25 ppm, while the carbon atom in the methylene group is observed at δ 64.62 ppm. Thus, 1H and 13C NMR spectra confirm the formation of the ligand as proposed.
The 1H NMR spectrum of the [Zn(II)(L)(Cl)(H2O)] complex in DMSO-d6 shows similar signals to that observed for HL (Figure 4 and Figure S4). Regarding the Zn(II) complex, the lack of a signal stemming from the proton in the phenolic OH group provides confirmation that the phenolic oxygen atom is engaged in bonding with the metal ion through deprotonation. The signals at δ 10.25–10.20, 8.47–7.71, 7.39–6.89, 4.13–4.08, and 1.40–1.35 are due to-CH=N-protons, pyrene protons, aromatic protons, -OCH2 protons, and methyl protons [20]. The broad signal at δ 6.31 may be attributed to coordinated water molecules. The large difference in chemical shift values for the hydrogen atom attached to the azomethine nitrogen compared with the ligand and Zn(II) complex suggests coordination through the azomethine nitrogen in the latter. With the presence of two peaks for each signal, we believe there may be an equilibrium between different conformations in solution and protons in the two halves of the molecules that are magnetically not equivalent.

2.1.3. Infrared Spectra and Coordination Mode

A comparison was made between the FTIR spectrum of the free ligand and the spectra of the complexes (Figures S5–S9). Table 5 shows the key IR bands along with their corresponding assignments. The presence of a strongly hydrogen-bonded OH group is suggested by a broad band observed at 3431 cm−1 in the Schiff base spectrum. This also implies that, in the solid state, the ligand is predominantly present in the enol form [21]. All metal complexes displayed broad bands within the range of 3433 to 3415 cm−1, signifying the existence of coordinated water molecules [20], but for Co(II)(L)2, this may be due to water of crystallization. The absorption band observed at 1605 cm−1 in the ligand’s spectrum is a result of the stretching vibration of ν(CH=N). However, in the case of the complexes, the frequency of the azomethine (CH=N) experiences a shift, either to a higher or lower field, indicating coordination through the azomethine nitrogen atom [22].
The aromatic ring ν(C=C) stretching vibration is observed in the region 1365–1492 cm−1. The stretching frequency ν(C-O) (phenolic) in the ligand is detected at 1252 cm−1 but experiences a shift to a lower frequency range within the complexes, ranging from 1208 to 1238 cm−1. This shift indicates bonding through the phenolic oxygen. The attachment of M(II) and M(III) atoms to the ligand via nitrogen and oxygen atoms is confirmed by the emergence of new bands at 527–626 cm−1 (assigned to ν(M − O) stretching) and 843–846 cm−1 (assigned to v(M − N) stretching) [23]. Therefore, based on the data gathered from the IR spectrum, it can be concluded that the coordination sites of the metal ion are -C=N and -CO.

2.1.4. Magnetic Moments and Electronic Spectral Data

Details about the geometry of the metal complexes were derived from their electronic absorption spectra and magnetic moment measurements, as provided in Table 6. Three bands can be observed in the electronic spectrum of the unbound Schiff base, the first two at 292 nm (34,247 cm−1) and 370 nm (27,027 cm−1) are due to the π-π* transition originating in the phenyl and pyrene rings, while the third band at 425 nm (23,529 cm−1) suggests the presence of n-π* transitions associated with the azomethine linkage (Figure 5) [24]. The absorption bands caused by π-π and n-π transitions in the spectrum of the free ligand, which were observed at higher energy, shifted in all spectra of metal complexes due to the coordination of the ligand with metal ions. As anticipated for a d10 system, the absence of d-d bands and diamagnetic behavior were observed in the Zn(II) complex. Based on conductance, analytical, and spectral data, the Zn(II) complex was assigned a tetrahedral geometry. The UV-Vis spectral data of the Cu(II) complex show two absorption bands above 347 nm, centered approximately within the ranges of 425 nm and 700 nm. It is possible that the band observed at a wavelength of 425 nm could be attributed to charge transfer from the nitrogen atoms to the copper ions [25]. The complex displays a broad band in the range of 650–750 nm, which is attributed to d-d electronic transitions (2T22E) and indicates the presence of Cu(II) ions in a distorted tetrahedral geometry. The magnetic moment value of the Cu(II) complex is 1.70 B.M., which is consistent with the 3d9 configuration having one unpaired electron in the 3d shell. A peak with a wavelength of 675 nm is observed in the electronic spectrum of the Co(II) complex. This peak is a result of the 4A2(F) → 4T1(P) transition, indicating the presence of a tetrahedral environment of the ligand surrounding the metal ion. Therefore, the geometry of the Co(II) complex can be identified as tetrahedral [26,27]. The magnetic moment value of 4.16 BM for the Co(II) complex is consistent with high-spin Co2+ ions, which is in agreement with the reported value for tetrahedral geometry. The electronic spectrum for the Cr(III) complex band exhibited at 680 nm is assigned to the 4A2g4T2g (F) transition, as expected for octahedral complexes [28]. The magnetic moment value of 3.61 B.M. for the Cr(III) complex indicates the presence of three unpaired electrons in its outer valence shell, creating a distorted octahedral geometry around the Cr(III) ion. Typically, electronic transitions in Fe(III) systems are considered spin forbidden and, therefore, relatively weak. However, in certain spin equilibrium systems, the high-spin (S = 5/2) configuration is associated with a transition occurring between 555 and 500 nm, and the low-spin (S = 1/2) configuration features a transition in the range of 714–625 nm. Analyzing the spectrum of the Fe(III) complex, it is evident that it displays a single band at 695 nm, which can be attributed to the 6A1g4T1g transition, a characteristic of an octahedral structure [29]. The room temperature magnetic moment of the Fe(III) complex is 5.91 B.M., which indicates that it is paramagnetic. This value was observed to be specific for octahedral complexes [30].

2.1.5. Mass Spectra

The ligand and its metal complexes were compared in terms of their stoichiometric composition using their ESI mass spectra. The data are presented in Table 7, and the spectra are displayed in Figure 6 and Figures S10–S14. A molecular ion peak was observed at m/z 366.155 for the ligand [HL]. This peak corresponds to [HL+H]+ (C25H20NO2), with a calculated m/z of 365.141. A molecular ion peak at m/z = 482.407 is observed in the mass spectrum of the Zn(II) complex, which is indicative of the [M+1]+ peak. Mass analysis with elemental analysis supports the structure of the complex and confirms the stoichiometry of metal chelates as of [Zn(II)(L)(Cl)(H2O)] type. The peak at m/z = 488.132 corresponds to an adduct of acetonitrile [M-Cl+CH3CN]+. In the spectrum of the Cu(II) complex, there is a peak observed at m/z = 519.208. This peak corresponds to an adduct of DMF, specifically [M-Cl+DMF]+. Mass and elemental analyses validate the complex’s structure and confirm that the metal chelates have a stoichiometry of [Cu(L)(Cl)(H2O)]. A peak at m/z = 788.218 is observed in the mass spectrum of the Co(II) complex, which is indicative of the [M+1]+ peak. Mass analysis with elemental analysis supports the structure of the complex and confirms the stoichiometry of metal chelates as of Co(L)2 type. The mass spectrum of the Cr(III) complex shows a peak at m/z = 432.160, which corresponds to the [M+1-2Cl-H2O]+ peak. The peak at m/z = 597.147 corresponds to an adduct of dimethyl formamide [M+2DMF-H2O-Cl]+. The structural integrity of the complex is verified, and the stoichiometry of the metal chelates is affirmed as being of the type of [Cr(L)(Cl)2(H2O)2] through mass and elemental analysis. The mass spectrum of the Fe(III) complex displayed a molecular ion peak at m/z = 526.84 for [M]+, and the peak at m/z = 599.891 corresponds to an adduct of dimethyl formamide [M+2DMF-2Cl]+. Mass analysis with elemental analysis supports the structure of the complex and confirms the stoichiometry of metal chelates of [Fe(III)(L)(Cl)2(H2O)2] type. In the mass spectra of metal complexes, various molecular ion peaks arise due to the fragmentation of the metal complex molecule. These peaks occur because of the rupture of different bonds within the molecule, leading to the formation of various radicals and many more important peaks. The molecular ion peaks observed in the spectra of these complexes correspond well with the structure proposed by spectral, magnetic, and elemental analysis studies.

2.1.6. ESR Spectrum of the Cu(II) Complex

The solid-state ESR spectrum of the [Cu(II)(L)(Cl)(H2O)] complex was measured at 300 K to obtain information about the geometry around the Cu metal ion. Diphenylpicrylhydrazyl (DPPH) as a g marker was used to obtain the g values. The spectrum exhibits four distinct but relatively weak peaks in the lower field region and one highly intense peak in the higher field region (see Figure 7). The magnetic susceptibility of 1.7 BM for the Cu(II) complex indicates the presence of a single unpaired electron, confirming the complex’s mononuclear nature. This conclusion is further supported by the absence of a half-field signal at 1600 G in the ESR spectrum, which rules out any Cu–Cu interactions [26]. The observed g values are as follows: g∥ (2.49) > g (2.18) > ge (2.0023), implying that the unpaired electron resides in the dx2-y2 orbital. The g∥/A∥ values of square planar complexes were reported within the range of 105–135 cm, whereas tetrahedral distorted complexes were in the range of 150–250 cm. The g∥/A∥ value of the Cu(II) complex of 205.79 cm is in the range expected for distorted tetrahedral rather than square planar complexes [14]. In the axial spectra, the g values are associated with the exchange interaction coupling constant (G). The observed G value of 2.72 in the current copper complex (where G < 4.0) indicates the presence of substantial exchange coupling, and there is a noticeable misalignment [26]. The covalency parameter α2, related to in-plane σ bonding as per Equation (1), was determined to be 0.51, suggesting the presence of covalent bonding. (An α2 value of 0.5 implies complete covalent bonding, while a value of 1.0 suggests complete ionic bonding.)
α2 = −(A∥ = 0:036) + (g∥ − 2.0036) + 3/7(g − 2.0036) + 0.04

2.2. Cytotoxic Activity

The cytotoxic effects of the newly synthesized Schiff base and its complexes were evaluated in vitro using the MTT colorimetric assay on the MCF-7 human breast cancer cell line (Table 8 and Table 9). The results include IC50 values, which represent the concentration (in μg/mL) of a compound required to induce 50% cell death compared with the control culture. As a reference, fluorouracil (5FU) was used. Notably, the MCF-7 cells displayed sensitivity to the Schiff base HL, with an IC50 value of 63.901 ± 3.67 μg/mL. The Cu(II) complex is the most cytotoxic, with an IC50 value of 5.661 ± 0.33 μg/mL, followed by the Zn(II) complex. The Cu(II) complex is the most effective compound, even more than the 5FU drug, followed by the Zn(II) complex and then the Fe(III) complex. All the complexes exhibit greater effectiveness against the human breast cancer cell line compared with the Schiff base ligand. The bonding of metal ions enhances the anticancer properties, as indicated by the complexes having lower IC50 values in comparison with the uncoordinated ligand.

3. Experimental Section

3.1. Materials and Instrumentation

We used commercially purchased reagents and solvents without further purification. 3-ethoxy salicylaldehyde and 1-aminopyrene were purchased from Sigma–Aldrich (Burlington, MA, USA). Zinc chloride hexahydrate (ZnCl2·6H2O), copper chloride dihydrate (CuCl2·6H2O), cobalt chloride hexahydrate (CoCl2·6H2O), chromium chloride hexahydrate (CrCl3·6H2O), and iron chloride anhydrous (FeCl3) were purchased from BDH chemicals (London, UK).
Elemental analyses were performed using a Thermo Flash 2000 CHN Elemental analyzer (Thermo Fisher Scientific, Waltham, MA, USA). Infrared spectra for the Schiff base ligand and its metal complexes were recorded in KBr pellets, employing a Perkin Elmer FT-IR Spectrometer within the range of 4000–400 cm−1 (Perkin Elmer, Inc., Waltham, MA, USA). Electronic spectra were recorded in DMSO for the ligand and its complexes in the range of 200–800 nm using a MultiSpec-1501 UV-VIS spectrophotometer (Shimadzu, Kyoto, Japan). These spectra were obtained at room temperature using 1.0 cm of quartz. 1H and 13C NMR spectra were scanned using an 850 MHz Brucker Ascend Spectrophotometer. Solid-state paramagnetic resonance (EPR) analysis was conducted using the continuous wave Bruker EMX PLUS spectrometer (Bruker BioSpin, Rheinstetten, Germany). The molar conductance measurements were carried out at room temperature using an OHAUS-STARER 3100C conductivity meter with a 0.001 M solution of complexes in DMSO (OHAUS Corporation, Parsippany, NJ, USA). The room temperature magnetic susceptibility was measured using Sherwood Scientific Magnetic susceptibility balance (Sherwood Scientific Ltd., Cambridge, UK).

3.2. Crystal Structure Determination of HL

The single-crystal X-ray data were gathered at a temperature of 150 K using a Bruker APEX-II CCD diffractometer. A graphite-monochromated MoKα radiation source (wavelength λ = 0.71073 A) and the w-scan technique were employed. The structures were initially solved through direct methods utilizing SHELXT [31] and subsequently refined using the full matrix least-squares method with SHELX integrated into the OLEX2 program suite v.1.2. Anisotropic displacement parameters were applied in the refinement of non-hydrogen atoms. All hydrogen atoms were determined from a different Fourier map and refined isotropically. Data collection: Bruker APEX2; cell refinement: Bruker SAINTl; and data reduction: Bruker SAINT. The general-purpose crystallographic tool PLATON v.2023.1 was used for the structure analysis [32]. MERCURY v.3.8 [33] and ORTEP-3 v.1.0.3 [34] were employed for the structural analysis and for presenting the results.

3.3. Synthesis of the Ligand (E)-2-Ethoxy-6-((pyren-1-ylimino)methyl)phenol (HL)

The 3-Ethoxysalicylaldehyde (0.083 g, 5 mmol) was dissolved in 30 mL of ethanol and, after complete dissolution, an equimolar amount of 1-aminopyrene (0.109 g, 5 mmol) dissolved in 30 mL of ethanol was added. Three drops of acetic acid anhydride were introduced into the reaction mixture as a catalyst. Subsequently, the solution was subjected to reflux for a duration of three hours, after which it was allowed to cool down to room temperature. The resulting precipitate was then collected and washed with ethanol to obtain the Schiff base, referred to as HL. Crystals of HL were obtained via slow evaporation of the dissolved compound in ethanol. Color: orange; yield: 96.69% (1.77 g); m.p.: 105 °C. Anal. calc., (C25H19NO2) C, 82.2; H, 5.2; N, 3.8 found, C,82.3; H, 5.3; N, 3.9. 1H NMR (850 MHz, DMSO, ppm) δ 13.61 (s, 1H, -OH), 9.28 (s, 1H, -CH=N-), 8.49 (d, 1H, J = 6.4 Hz, pyrene), 8.41 (d, 1H, J = 8.84 Hz, pyrene), 8.33 (m, 2H, pyrene), 8.32 (d,1H, J = 9.49 Hz, pyrene), 8.22–8.18 (m, 3H, pyrene), 8.12 (t, 1H, J = 8.33 Hz, pyrene), 7.42 (d, J = 9.1 Hz, 1H, Ar-H), 7.21 (d, J = 7.2 Hz, 1H, Ar-H), 6.99 (t, J = 8.04 Hz, 1H, Ar-H), 4.14 (q, J = 7.07 Hz, 2H, -OCH2), 1.43 (t, J = 7.07, 3H, -CH3). 13C NMR (850 MHz, DMSO, ppm) δ 164.97 (-CH=N-), 151.25 (Ar-C-N), 147.61 (Ar-C-OH), 142.06 (Ar-C-OEt), 131.46–116.80 (Ar-C), 64.26 (CH2), 15.25 (CH3).

3.4. Synthesis of the Schiff Base Metal Complexes

The prepared metal complexes were synthesized as follows: the Schiff base HL (0.731 g, 2 mmol) was dissolved in 40 mL of ethanol and combined with an ethanolic solution of ZnCl2·6H2O, CuCl2·6H2O, and CoCl2·6H2O (2 mmol, 20 mL). For the Cr(III) and Fe(III) complexes, a solution of HL was dissolved in 20 mL of ethanol and then added to an ethanolic solution of CrCl3·6H2O and FeCl3 (1 mmol, 10 mL). The resulting solutions were stirred magnetically and refluxed for three hours. After cooling, the resulting precipitates were collected using filtration, washed several times with hot ethanol, and dried. All the complexes were stable in the presence of air and moisture. The data regarding the analysis and physical properties of the ligand (HL) and the metal complexes can be found in Table 1.
For [Zn(II)(L)(Cl)(H2O)], a red solid was obtained; m.p.: 215 °C; yield (22.9%, 0.22 g). 1H NMR (850 MHz, DMSO, ppm) δ 10.25, 10.20 (s, 1H, -CH=N-), 8.50–7.71 (m, 9H, pyrene), 7.39–6.89 (3H Ar-H), 6.31 (s, 2H, Zn-H2O), 4.14, 4.09 (q, 2H, -OCH2), 1.4, 1.35 (t, 3H, -CH3).
  • For [Cu(II)(L)(Cl)(H2O)], a black solid was obtained; m.p.: >250 °C with decomposition; yield (72.5%, 0.696 g).
  • For [Co(II)(L)2], a dark red solid was obtained; m.p.: >250 °C with decomposition; yield (44.0%, 0.694 g).
  • For [Cr(III)(L)(Cl)2(H2O)2], a pale brown solid was obtained; m.p.: >250 °C with decomposition; yield (16.9%, 0.090 g).
  • For [Fe(III)(L)(Cl)2(H2O)], a black solid was obtained; m.p.: >250 °C with decomposition; yield (49.59%, 0.261 g).

3.5. Sample Preparation and Analysis for Mass Analysis

The samples were dissolved in DMF. An approximately 10 microliter aliquot of the dissolved sample was further diluted 1000-fold in acetonitrile. No precipitation or cloudiness was observed. Analysis was performed via flow injection whereby 5 mL of each sample was injected into the LC flow of 100 acetonitrile mobile phase composition and directly introduced into the MS electrospray ionization source for ionization generation. The experiments were conducted on a QTOF MS using an ESI ionization source. The MS data were externally calibrated using calibration data of sodium formate clusters.

3.6. Cell Viability Test

Cell viability was evaluated through the MTT assay using mononuclear cells. This method is based on the reduction of a soluble yellow tetrazolium salt into insoluble purple formazan crystals by metabolically active cells. Within the mitochondria of live cells, the enzyme mitochondrial succinate dehydrogenase transforms the internalized tetrazolium salt into purple formazan crystals. The cells are then lysed and dissolved in a DMSO solution. The resulting color change is measured using an ROBONIK P2000 Elisa Reader at 570 nm (India PVT LTD., Thane, India). For the assay, the MCF-7 human breast cancer cell line is plated separately in 96-well plates at a concentration of 1 × 105 cells per well. After 24 h, the cells are washed twice with 100 μL of serum-free medium and starved for an hour at 37 °C. Subsequently, the cells are treated with varying concentrations of the test compound (ranging from 0.4 to 100 μg/mL) for 24 h. At the end of the treatment period, the medium is removed, and a serum-free medium containing MTT (0.5 mg/mL) is added, followed by incubation for 4 h at 37 °C in a CO2 incubator. The MTT-containing medium is then discarded, the cells are washed with PBS (200 μL), and the crystals are dissolved by adding 100 μL of DMSO. This solution is thoroughly mixed via pipetting. The spectrophotometric absorbance of the purple–blue formazan dye is measured using a microplate reader at 570 nm [35,36].

4. Conclusions

In this work, we synthesized a novel pyrene-based Schiff base by reacting 3-ethoxy salicylaldehyde and 1-aminopyrene and conducted a detailed analysis of its crystallographic data. Furthermore, we synthesized and characterized Zn(II), Cu(II), Co(II), Cr(III), and Fe(III) complexes of this Schiff base using various techniques, including elemental analysis, mass spectrometry, infrared spectroscopy, and magnetic measurements. The results clearly demonstrate the bidentate nature of the Schiff base ligand. In all of these complexes, the metal-to-ligand stoichiometry is 1:1, with the exception of the Co(II), which exhibits a 1:2 ratio. Electronic and ESR spectral studies suggest distorted tetrahedral geometry for the Cu(II) complex. The Zn(II) and Co(II) complexes adopt tetrahedral geometry, while the Cr(III) and Fe(III) complexes exhibit distorted octahedral geometry. We also assessed the cytotoxicity of these metal complexes and found that the [Cu(II)(L)(Cl)(H2O)] complex exhibited a superior cytotoxic effect on MCF-7 cancer cells, with an IC50 value of 5.661 ± 0.33 μg/mL. This IC50 value is significantly lower than that of the standard cancer drug fluorouracil (IC50 = 18.047 ± 1.04 μg/m). These results indicate that the Cu(II) complex may have the potential to be utilized as a traditional anticancer agent. However, further comprehensive in vivo experiments are necessary to substantiate its anticancer effectiveness.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28217352/s1, Figure S1: 1H NMR spectrum of the ligand HL; Figure S2: Expanded region between 6 and 9 ppm for the 1H NMR of HL; Figure S3: 13C NMR spectrum of the ligand HL; Figure S4: Expanded region between 6 and 9 ppm for the 1H NMR of [Zn(II)(L)(Cl)(H2O)]; Figure S5: IR spectrum of HL; Figure S6: IR spectrum of [Zn(II)(L)(Cl)(H2O)]; Figure S7: IR spectrum of [Cu(II)(L)(Cl)(H2O)]; Figure S8: IR spectrum of [Co(II)(L)2]; Figure S9: IR spectrum of [Fe(III)(L)(Cl)2(H2O)2]; Figure S10: Mass spectrum of [Zn(II)(L)(Cl)(H2O)]; Figure S11: Mass spectrum of [Cu(II)(L)(Cl)(H2O)]; Figure S12: Mass spectrum of [Co(II)(L)2]; Figure S13: Mass spectrum of [Cr(III)(L)(Cl)2(H2O)2]; Figure S14: mass spectrum of [Fe(III)(L)(Cl)2(H2O)2].

Author Contributions

Conceptualization, E.S.A. and M.A.M.; methodology, E.S.A. and M.A.M.; formal analysis, E.S.A. and M.A.M.; investigation, E.S.A. and M.A.M.; resources, E.S.A. and M.A.M.; writing—original draft preparation, E.S.A. and M.A.M.; writing—review and editing, E.S.A. and M.A.M.; supervision, E.S.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ma, Z.-Y.; Qiao, X.; Xie, C.-Z.; Shao, J.; Xu, J.-Y.; Qiang, Z.-Y.; Lou, J.-S. Activities of a novel Schiff Base copper (II) complex on growth inhibition and apoptosis induction toward MCF-7 human breast cancer cells via mitochondrial pathway. J. Inorg. Biochem. 2012, 117, 1–9. [Google Scholar] [CrossRef] [PubMed]
  2. Kumar, M.; Darolia, P.J.; Chauhan, S.; Sindhu, M.; Verma, K.; Garg, S. Synthesis, Spectroscopic, Biological Activity, Molecular Docking and Density Functional Theoretical Investigations of Novel Tellurium (IV) Schiff Base Complexes. ChemistrySelect 2021, 6, 5778–5790. [Google Scholar] [CrossRef]
  3. El-Bindary, M.A.; El-Bindary, A.A. Synthesis, characterization, DNA binding, and biological action of dimedone arylhydrazone chelates. Appl. Organomet. Chem. 2022, 36, e6576. [Google Scholar] [CrossRef]
  4. Al-Humaidi, J.Y. In situ alkaline media: Synthesis, spectroscopic, morphology and anticancer assignments of some transition metal ion complexes of 1-((2-aminophenylimino) methyl) naphthalen-2-ol Schiff base. J. Mol. Struct. 2019, 1183, 190–201. [Google Scholar] [CrossRef]
  5. Shabbir, M.; Akhter, Z.; Ismail, H.; Mirza, B. Synthetic bioactive novel ether based Schiff bases and their copper (II) complexes. J. Mol. Struct. 2017, 1146, 57–61. [Google Scholar] [CrossRef]
  6. El-Gammal, O.A.; El-Bindary, A.A.; Mohamed, F.S.; Rezk, G.N.; El-Bindary, M.A. Synthesis, characterization, design, molecular docking, anti COVID-19 activity, DFT calculations of novel Schiff base with some transition metal complexes. J. Mol. Liq. 2022, 346, 117850. [Google Scholar] [CrossRef]
  7. Bhorge, Y.R.; Tsai, H.-T.; Huang, K.-F.; Pape, A.J.; Janaki, S.N.; Yen, Y.-P. A new pyrene-based Schiff-base: A selective colorimetric and fluorescent chemosensor for detection of Cu (II) and Fe (III). Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2014, 130, 7–12. [Google Scholar] [CrossRef] [PubMed]
  8. Srinivasan, V.; Jhonsi, M.A.; Dhenadhayalan, N.; Lin, K.-C.; Ananth, D.A.; Sivasudha, T.; Narayanaswamy, R.; Kathiravan, A. Pyrene-based prospective biomaterial: In Vitro bioimaging, protein binding studies and detection of bilirubin and Fe3+. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2019, 221, 117150. [Google Scholar] [CrossRef]
  9. Dalbera, S.; Kulovi, S.; Dalai, S. Pyrene-based Schiff Base as Selective Chemosensor for Copper (II) and Sulfide Ions. ChemistrySelect 2018, 3, 6561–6569. [Google Scholar] [CrossRef]
  10. Kumar, V.; Kumar, P.; Kumar, S.; Singhal, D.; Gupta, R. Turn-on fluorescent sensors for the selective detection of Al3+ (and Ga3+) and PPi ions. Inorg. Chem. 2019, 58, 10364–10376. [Google Scholar] [CrossRef]
  11. Yeldir, E.K.; Kaya, İ. Synthesis, characterization and investigation of fluorescent Sn2+ probe potential of pyrene-derived monomer and its oligo (azomethine) compound. Eur. Polym. J. 2022, 172, 111229. [Google Scholar] [CrossRef]
  12. Silva, C.S.; Moutinho, C.; Ferreira da Vinha, A.; Matos, C. Trace minerals in human health: Iron, zinc, copper, manganese and fluorine. Int. J. Sci. Res. Methodol. 2019, 13, 57–80. [Google Scholar]
  13. El-Attar, M.; Aazam, E. Redox behavior, spectroscopic investigations, theoretical interpretation and biological effectiveness of some novel prepared bis-azomethine derivatives and their copper (II) complexes. J. Coord. Chem. 2021, 74, 779–803. [Google Scholar] [CrossRef]
  14. Aazam, E.S.; Zaki, M. Synthesis and characterization of Ni (II)/Zn (II) metal complexes derived from Schiff base and ortho-phenylenediamine: In vitro DNA binding, molecular modeling and RBC hemolysis. ChemistrySelect 2020, 5, 610–618. [Google Scholar] [CrossRef]
  15. Saritha, T.; Metilda, P. Synthesis, spectroscopic characterization and biological applications of some novel Schiff base transition metal (II) complexes derived from curcumin moiety. J. Saudi Chem. Soc. 2021, 25, 101245. [Google Scholar] [CrossRef]
  16. Aazam, E.S.; Büyükgüngör, O. 2-Amino-3-[(E)-(2-hydroxy-3-methylbenzylidene) amino] but-2-enedinitrile. Acta Crystallogr. Sect. E Struct. Rep. Online 2012, 68, o1406. [Google Scholar] [CrossRef] [PubMed]
  17. Hökelek, T.; Kılıç, Z.; Isıklan, M.; Toy, M. Intramolecular hydrogen bonding and tautomerism in Schiff bases. Part II. Structures of 1-[N-(2-pyridyl) aminomethylidene}-2 (1H)-naphtalenone (1) and bis [2-hydroxy-κO–N-(2-pyridyl)-1-naphthaldiminato-κN] zinc (II)(2). J. Mol. Struct. 2000, 523, 61–69. [Google Scholar] [CrossRef]
  18. Aazam, E.S.; Büyükgüngör, O. 7-[(3,5-Di-tert-butyl-2-hydroxybenzylidene) amino]-4-methyl-2H-chromen-2-one. Acta Crystallogr. Sect. E Struct. Rep. Online 2010, 66, o2587–o2588. [Google Scholar] [CrossRef]
  19. Durran, S.E.; Elsegood, M.R.; Hammond, S.R.; Smith, M.B. Coordination Studies of a New Unsymmetrical κ4-PNN′N″-Tetradentate Ligand: Stepwise Formation and Structural Characterization. Inorg. Chem. 2007, 46, 2755–2766. [Google Scholar] [CrossRef] [PubMed]
  20. Mounika, K.; Pragathi, A.; Gyanakumari, C. Synthesis characterization and biological activity of a Schiff base derived from 3-ethoxy salicylaldehyde and 2-amino benzoic acid and its transition metal complexes. J. Sci. Res. 2010, 2, 513. [Google Scholar] [CrossRef]
  21. Dhahagani, K.; Kumar, S.M.; Chakkaravarthi, G.; Anitha, K.; Rajesh, J.; Ramu, A.; Rajagopal, G. Synthesis and spectral characterization of Schiff base complexes of Cu (II), Co (II), Zn (II) and VO (IV) containing 4-(4-aminophenyl) morpholine derivatives: Antimicrobial evaluation and anticancer studies. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2014, 117, 87–94. [Google Scholar] [CrossRef] [PubMed]
  22. Sunitha, M.; Jogi, P.; Ushaiah, B.; Kumari, C.G. Synthesis, characterization and antimicrobial activity of transition metal complexes of Schiff base ligand derived from 3-ethoxy salicylaldehyde and 2-(2-Aminophenyl) 1-H-benzimidazole. E J. Chem. 2012, 9, 2516–2523. [Google Scholar] [CrossRef]
  23. Durak, D.; Delikanlı, A.; Demetgül, C.; Kani, İ.; Serin, S. Crystal structure of an unsymmetrical Schiff base, immobilization of its cobalt and manganese complexes on a silica support, and catalytic studies. Transit. Met. Chem. 2013, 38, 199–206. [Google Scholar] [CrossRef]
  24. Pahonțu, E.; Ilieș, D.-C.; Shova, S.; Paraschivescu, C.; Badea, M.; Gulea, A.; Roșu, T. Synthesis, characterization, crystal structure and antimicrobial activity of copper (II) complexes with the Schiff base derived from 2-hydroxy-4-methoxybenzaldehyde. Molecules 2015, 20, 5771–5792. [Google Scholar] [CrossRef] [PubMed]
  25. Amer, S.; El-Wakiel, N.; El-Ghamry, H. Synthesis, spectral, antitumor and antimicrobial studies on Cu (II) complexes of purine and triazole Schiff base derivatives. J. Mol. Struct. 2013, 1049, 326–335. [Google Scholar] [CrossRef]
  26. Joseyphus, R.S.; Nair, M.S. Synthesis, characterization and biological studies of some Co (II), Ni (II) and Cu (II) complexes derived from indole-3-carboxaldehyde and glycylglycine as Schiff base ligand. Arab. J. Chem. 2010, 3, 195–204. [Google Scholar] [CrossRef]
  27. Abdel-Rahman, L.H.; Abu-Dief, A.M.; Newair, E.F.; Hamdan, S.K. Some new nano-sized Cr (III), Fe (II), Co (II), and Ni (II) complexes incorporating 2-((E)-(pyridine-2-ylimino) methyl) napthalen-1-ol ligand: Structural characterization, electrochemical, antioxidant, antimicrobial, antiviral assessment and DNA interaction. J. Photochem. Photobiol. B Biol. 2016, 160, 18–31. [Google Scholar]
  28. Al-Fakeh, M.S.; Alsikhan, M.A.; Alnawmasi, J.S. Physico-Chemical Study of Mn (II), Co (II), Cu (II), Cr (III), and Pd (II) Complexes with Schiff-Base and Aminopyrimidyl Derivatives and Anti-Cancer, Antioxidant, Antimicrobial Applications. Molecules 2023, 28, 2555. [Google Scholar] [CrossRef]
  29. Saghatforoush, L.A.; Aminkhani, A.; Chalabian, F. Iron (III) Schiff base complexes with asymmetric tetradentate ligands: Synthesis, spectroscopy, and antimicrobial properties. Transit. Met. Chem. 2009, 34, 899–904. [Google Scholar] [CrossRef]
  30. Capan, A.; Uruş, S.; Sönmez, M. Ru (III), Cr (III), Fe (III) complexes of Schiff base ligands bearing phenoxy Groups: Application as catalysts in the synthesis of vitamin K3. J. Saudi Chem. Soc. 2018, 22, 757–766. [Google Scholar] [CrossRef]
  31. Sheldrick, G.M. SHELXT–Integrated space-group and crystal-structure determination. Acta Crystallogr. Sect. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  32. Spek, A. Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 2003, 36, 7–13. [Google Scholar] [CrossRef]
  33. Macrae, C.F.; Edgington, P.R.; McCabe, P.; Pidcock, E.; Shields, G.P.; Taylor, R.; Towler, M.; Streek, J. Mercury: Visualization and analysis of crystal structures. J. Appl. Crystallogr. 2006, 39, 453–457. [Google Scholar] [CrossRef]
  34. Farrugia, L.J. WinGX and ORTEP for Windows: An update. J. Appl. Crystallogr. 2012, 45, 849–854. [Google Scholar] [CrossRef]
  35. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef] [PubMed]
  36. Edmondson, J.M.; Armstrong, L.S.; Martinez, A.O. A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures. J. Tissue Cult. Methods 1988, 11, 15–17. [Google Scholar] [CrossRef]
Scheme 1. Synthesis pathway of HL.
Scheme 1. Synthesis pathway of HL.
Molecules 28 07352 sch001
Figure 1. Proposed structures for metal complexes.
Figure 1. Proposed structures for metal complexes.
Molecules 28 07352 g001
Figure 2. The molecular structure of HL, with atom labeling. Displacement ellipsoids are drawn at the 50% probability level.
Figure 2. The molecular structure of HL, with atom labeling. Displacement ellipsoids are drawn at the 50% probability level.
Molecules 28 07352 g002
Figure 3. The crystal packing of HL viewed along an axis. The C-H···π interactions linking the molecules are shown as dashed lines.
Figure 3. The crystal packing of HL viewed along an axis. The C-H···π interactions linking the molecules are shown as dashed lines.
Molecules 28 07352 g003
Figure 4. 1H NMR spectrum of [Zn(II)(L)(Cl)(H2O)].
Figure 4. 1H NMR spectrum of [Zn(II)(L)(Cl)(H2O)].
Molecules 28 07352 g004
Figure 5. The UV-vis spectrum of HL and its metal complexes in the range of 250–800 nm.
Figure 5. The UV-vis spectrum of HL and its metal complexes in the range of 250–800 nm.
Molecules 28 07352 g005
Figure 6. Mass spectrum of HL.
Figure 6. Mass spectrum of HL.
Molecules 28 07352 g006
Figure 7. ESR spectrum of Cu(II) Schiff base complexes at 300 K.
Figure 7. ESR spectrum of Cu(II) Schiff base complexes at 300 K.
Molecules 28 07352 g007
Table 1. Analytical data and physical properties of ligand HL and its complexes.
Table 1. Analytical data and physical properties of ligand HL and its complexes.
CompoundsEmpirical FormulaMol. wt. (g/mol)ColorM.p. (°C)Yield (%)Elemental Found (calc.)Ω (O hm−1 cm2 mol−1)
CHN
HLC25H19NO2365.4Orange10596.6982.3 (82.2)5.3 (5.2)3.9 (3.8)-
Zn(II)(L)(Cl)(H2O)C25H20ClNO3Zn481.0red21522.9361.9 (62.1)4.2 (4.2)3.1 (2.9)2.05
Cu(II)(L)(Cl)(H2O)C25H20ClNO3Cu480.0Black>25072.562.3 (62.4)3.9 (4.2)3.0 (2.9)5.53
Co(II)(L)2C50H36N2O4Co787.8Dark red>25044.075.9 (76.2)4.5 (4.6)3.6 (3.6)12.4
Cr(III)(L)(Cl)2(H2O)2C25H22Cl2NO4Cr533.0Pale Brown>25016.957.6 (57.4)4.2 (4.3)2.8 (2.7)15.15
Fe(III)(L)(Cl)2(H2O)2C25H22Cl2NO4Fe526.0Black>25049.5957.2 (57.0)4.1 (4.2)2.6 (2.7)10.15
Table 2. Crystal data and structure refinement of HL.
Table 2. Crystal data and structure refinement of HL.
Crystal Data
Chemical formulaC25H19NO2
Mr365.41
Crystal system, space groupTriclinic, P1
Temperature (K)150
a, b, c (Å)7.0543 (13), 11.503 (2), 11.988 (2)
α, β, γ (°)104.225 (7), 97.308 (7), 102.335 (8)
V3)904.4 (3)
Z2
Radiation typeMo Kα
µ (mm−1)0.09
Crystal size (mm)× ×
Data collection
DiffractometerBruker APEX-II CCD
Absorption correction
No. of measured, independent, and
observed [I > 2σ(I)] reflections
20,633, 3078, 2033
Rint0.110
(sin θ/λ)max−1)0.588
Refinement
R[F2 > 2σ(F2)], wR(F2), S0.060, 0.132, 1.08
No. of reflections3078
No. of parameters256
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å−3)0.22, −0.20
Table 3. Selected bond lengths (Å) and bond angles (°) for HL.
Table 3. Selected bond lengths (Å) and bond angles (°) for HL.
Bond Lengths (Å)Bond Lengths (Å)
O1-C111.372 (3)C11-O1-C12117.5 (2)
O1-C121.443 (3)C8-N1-C7122.0 (2)
O2-C101.353 (3)C6-C7-N1117.3 (2)
N1-C71.415 (3)C19-C7-N1122.6 (2)
N1-C81.282 (3)N1-C8-C9121.2 (3)
O1-C111.372 (3)O2-C10-C9122.3 (2)
O1-C121.443 (3)O2-C10-C11117.7 (2)
N1-C81.282 (3)O1-C12-C13106.9 (2)
C11-C141.374 (4)
C12-C131.503 (4)
C14-C151.407 (4)
Table 4. 1H NMR spectral data of the ligan HL.
Table 4. 1H NMR spectral data of the ligan HL.
Chemical Shift
(δ, ppm)
MultiplicityNumber of ProtonsFunctional Group Assigned
13.61Singlet1-OH
9.28Singlet1-CH=N-
8.49–8.12Multiplet9Pyrene protons
7.42–6.99Doublet3Aromatic protons
4.14Quartet2-OCH2
1.43Triplet3-CH3
Table 5. Characteristic IR bands (cm−1) of HL and its metal complexes.
Table 5. Characteristic IR bands (cm−1) of HL and its metal complexes.
CompoundvOH/
vH2O
vC=NvC=CvC-OvC-NvM-NvM-O
HL3431 1605145912521186--
Zn(II)(L)(Cl)(H2O)34151631149212351118843608
Cu(II)(L)(Cl)(H2O)34161596136512081132844613
Co(II)(L)234151631149212341118843626
Cr(III)(L)(Cl)2(H2O)234201738136512281216846527
Fe(III)(L)(Cl)2(H2O)234331629148212381189845607
Table 6. Magnetic moments and electronic spectral data for complexes.
Table 6. Magnetic moments and electronic spectral data for complexes.
Ligand and ComplexesVmax (nm)µeff. (B.M)Geometrydn
HL292, 370, 425---
Zn(II)(L)(Cl)(H2O)295, 380, 430DiamagneticTetrahedrald10
Cu(II)(L)(Cl)(H2O)275, 347, 425, 7001.70Distorted tetrahedrald9
Co(II)(L)2293, 390, 410, 6754.16Tetrahedrald7
Cr(III)(L)(Cl)2(H2O)2300, 399, 625, 7253.61Distorted octahedrald3
Fe(III)(L)(Cl)2(H2O)2311, 385, 6955.91Distorted octahedrald5
n—number of electrons.
Table 7. Mass spectral data of the ligand and its complexes.
Table 7. Mass spectral data of the ligand and its complexes.
CompoundExpected m/zFound m/zPeak Assigned
HL365366[M+1]+
Zn(II)(L)(Cl)(H2O)481482[M+1]+
Cu(II)(L)(Cl)(H2O)480519[M-Cl+DMF]+
Co(II)(L)2787788[M+1]+
Cr(III)(L)(Cl)2(H2O)2522432[M+1-2Cl-H2O]+
Fe(III)(L)(Cl)2(H2O)2526527[M+1]+
Table 8. The percentage of cell viability after treatment of MCF-7 cells with different concentrations of samples.
Table 8. The percentage of cell viability after treatment of MCF-7 cells with different concentrations of samples.
Sample100 μg25 μg6.3 μg1.6 μg0.4 μg
HL46.8856.8864.2576.4483.44
Zn(II)(L)(Cl)(H2O)38.0347.1352.7564.1668.00
Cu(II)(L)(Cl)(H2O)29.4440.3649.3059.0168.46
Co(II)(L)235.0649.5062.8172.0679.94
Cr(III)(L)(Cl)2(H2O)245.8156.5465.3075.3284.14
Fe(III)(L)(Cl)2(H2O)238.6546.5256.0466.8576.13
5FU b37.6347.4059.4466.0076.15
b Fluorouracil cancer drug used as a positive control.
Table 9. In vitro antiproliferative activities of HL and its metal complexes against the MCF-7 human tumor cell line.
Table 9. In vitro antiproliferative activities of HL and its metal complexes against the MCF-7 human tumor cell line.
CompoundCytotoxicity IC50 a
μg/mL
SD ±
HL63.9013.67
Zn(II)(L)(Cl)(H2O)12.7420.73
Cu(II)(L)(Cl)(H2O)5.6610.33
Co(II)(L)221.1411.21
Cr(III)(L)(Cl)2(H2O)258.7083.37
Fe(III)(L)(Cl)2(H2O)216.8950.97
5FU b18.0471.04
a The concentration that causes a 50% cell proliferation inhibition. b Fluorouracil cancer drug used as a positive control.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Aazam, E.S.; Majrashi, M.A. Novel Schiff Base Derived from Amino Pyrene: Synthesis, Characterization, Crystal Structure Determination, and Anticancer Applications of the Ligand and Its Metal Complexes. Molecules 2023, 28, 7352. https://doi.org/10.3390/molecules28217352

AMA Style

Aazam ES, Majrashi MA. Novel Schiff Base Derived from Amino Pyrene: Synthesis, Characterization, Crystal Structure Determination, and Anticancer Applications of the Ligand and Its Metal Complexes. Molecules. 2023; 28(21):7352. https://doi.org/10.3390/molecules28217352

Chicago/Turabian Style

Aazam, Elham S., and Maryam A. Majrashi. 2023. "Novel Schiff Base Derived from Amino Pyrene: Synthesis, Characterization, Crystal Structure Determination, and Anticancer Applications of the Ligand and Its Metal Complexes" Molecules 28, no. 21: 7352. https://doi.org/10.3390/molecules28217352

APA Style

Aazam, E. S., & Majrashi, M. A. (2023). Novel Schiff Base Derived from Amino Pyrene: Synthesis, Characterization, Crystal Structure Determination, and Anticancer Applications of the Ligand and Its Metal Complexes. Molecules, 28(21), 7352. https://doi.org/10.3390/molecules28217352

Article Metrics

Back to TopTop